PAVmed Inc.

PAVmed Inc. is identified as a 10% Owner of Lucid Diagnostics Inc. This profile examines the company's recent SEC Form 4 activity, capturing two public disclosures related to its investments. The disclosure period spans from January 30, 2024, to February 20, 2024, highlighting a significant financial involvement of approximately $4.7 million, with the largest disclosed move being an action valued at $4.67 million on January 30, 2024. The focus remains on the healthcare sector, reflecting a concentrated investment strategy.